Fierce Biotech

Pfizer sues Metsera over Novo's shock counteroffer, but obesity biotech stands firm

For Novo, it marks the boldest move yet for recently appointed CEO Maziar Mike Doustdar. In response to a slowdown in sales ...

Is It Time to Dump Your Shares of Pfizer?

Pfizer also has set its sights on becoming a giant in oncology, and to support this, completed the acquisition of Seagen in ...

Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera

Pfizer has now filed a suit in federal court, following its claim in state court on Friday. It is riding Trump-era political currents in its efforts to save the deal.
pharmaphorum

Pfizer files another lawsuit against Metsera, Novo Nordisk

After filing one lawsuit to try to block Novo Nordisk's $9 billion effort to trump the takeover, Pfizer has returned to the ...
PharmExec

Pfizer Files Lawsuits Against Metsera and Novo Nordisk

Pfizer's lawsuits target Metsera, its directors, and Novo Nordisk for breach of contract and antitrust violations, focusing on Novo Nordisk's acquisition proposal. The first lawsuit claims Novo ...

Pfizer (PFE) Q3 Earnings: What To Expect

Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s ...

Pfizer Q3 Earnings Preview: Results to test recovery hopes amid TrumpRx deal, Metsera dispute

Pfizer ( PFE) is set to report its Q3 earnings on Tuesday, November 4, before the market opens. Wall Street expects earnings ...

Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal

Drugmaker Pfizer on Friday sued obesity-drug developer Metsera and Novo Nordisk, seeking to block Metsera from terminating ...